快而精医药(QGEN)

49.70 0.73 1.4907%

今开:49.5昨收:48.97
最高:49.77 最低:49.42
涨停价:0.0跌停价:0.0
总市值:1.131669E10

快而精医药的热门评论

美股滚雪球2021-11-04 11:25

有报道称$快而精医药(QGEN)$ 吸引了法国诊断公司bioMérieux的收购兴趣。
去年,$赛默飞世尔科技(TMO)$ 出价104亿欧元收购QGEN,但最终交易破裂,一周后Qigen董事长辞职,这次董事长还辞职吗?
$东方生物(SH688298)$查看全文

美股滚雪球2021-11-17 12:09

$赛默飞世尔科技(TMO)$ 据说又想并购$快而精医药(QGEN)$ 了,念念不忘,必有回响。$义翘神州(SZ301047)$查看全文

财报披露

快而精医药(QGEN)11-09 19:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000045 Act: 34 Size: 544 KB 网页链接查看全文

财报披露

快而精医药(QGEN)11-09 19:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000047 Act: 34 Size: 1 MB 网页链接查看全文

财报披露

快而精医药(QGEN)11-09 19:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000042 Act: 34 Size: 7 MB 网页链接查看全文

7X24快讯2021-07-12 23:14

市场消息:快而精医药(QGEN.N)将回购高达1亿美元股票。查看全文

JZee2021-06-21 09:41

$泛生子(GTH)$ 主页上有$快而精医药(QGEN)$ 合作字样。泛生子目前的检测服务和未来的肝癌早筛需给qiagen分成么?//@userfield:回复@张小丰:我倒是觉得这个行业现在不需要一口吃个胖子吧,应该是渐进式进步,先比临床日常用的检测方法有更好的灵敏度和特异性,然后采样方便,这样就有一定优势,可以...查看全文

财报披露

快而精医药(QGEN)07-29 18:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000040 Act: 34 Size: 1 MB 网页链接查看全文

财报披露

快而精医药(QGEN)07-28 18:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000037 Act: 34 Size: 533 KB 网页链接查看全文

快而精医药(QGEN)2021-05-05 18:42

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-21-000031 Act: 34 Size: 1 MB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

快而精医药的最新评论

快而精医药(QGEN)2020-03-03 19:20

$快而精医药(QGEN)$ SC TO-C Written communication relating to an issuer or third party Accession Number: 0001104659-20-028178 Act: 34 Size: 4 MB 网页链接查看全文

chuminhua2020-03-03 17:06

3/3,赛默飞世尔科技公司(Thermo Fisher$赛默飞世尔科技(TMO)$ )和凯杰(QIAGEN$快而精医药(QGEN)$ )联合宣布,双方董事会已一致批准Thermo Fisher提出的以每股39欧元现金收购QIAGEN的提议,这个价格是QIAGEN前一天收盘价的23%溢价。赛默飞世尔将开始要约收购QIAGEN的所有普通股。以当前汇率计...查看全文

快而精医药(QGEN)2020-03-02 19:15

$快而精医药(QGEN)$ IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). Accession Number: 0001015820-20-000016 Act: 34 Size: 33 KB 网页链接查看全文

快而精医药(QGEN)2020-03-02 19:10

$快而精医药(QGEN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001015820-20-000015 Act: 34 Size: 22 MB 网页链接查看全文

快而精医药(QGEN)2020-02-14 19:16

$快而精医药(QGEN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000912938-20-000145 Act: 34 Size: 17 KB 网页链接查看全文

快而精医药(QGEN)2020-02-13 04:00

$快而精医药(QGEN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-20-019105 Act: 34 Size: 70 KB 网页链接查看全文

快而精医药(QGEN)2020-02-05 19:11

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-20-000003 Act: 34 Size: 633 KB 网页链接查看全文

快而精医药(QGEN)2020-02-05 01:56

$快而精医药(QGEN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-20-002669 Act: 34 Size: 13 KB 网页链接查看全文

快而精医药(QGEN)2020-01-28 23:05

$快而精医药(QGEN)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902219-20-000217 Act: 34 Size: 33 KB 网页链接查看全文

Rax郝毅2020-01-18 21:45

回复@JZee: 这两家是竞争对手是吧?我去看看//@JZee:回复@Rax郝毅:$快而精医药(QGEN)$, thermo Fisher, $Natera(NTRA)$ 也可以看看查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

快而精医药的公告

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000047 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000042 Act: 34 Size: 7 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000045 Act: 34 Size: 544 KB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000040 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000037 Act: 34 Size: 533 KB 网页链接

专项披露公告

$快而精医药(QGEN)$ SD Specialized disclosure report Accession Number: 0001015820-22-000031 Act: 34 Size: 44 KB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000026 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000024 Act: 34 Size: 443 KB 网页链接

定期披露文件

$快而精医药(QGEN)$ IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). Accession Number: 0001015820-22-000020 Act: 34 Size: 102 KB 网页链接

年度财报

$快而精医药(QGEN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001015820-22-000017 Act: 34 Size: 24 MB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30